Accurate Education – Nutraceutical Protocols:  Chronic Low Back Pain

Nutraceutical Protocols: 

Chronic Low Back Pain (LBP)

Chronic lower back pain, lasting 12 weeks or more, maybe the result of many different pathologic conditions. Conventional.treatment of LBP may include. physical therapy, pain medications, injections, or, rarely, surgery. Unfortunately, these treatments are often insufficient to provide adequate control of that pain, and the use of nutraceuticals may be advised as adjuvant means of reducing low back pain.

See:  

• • Nutraceutical Protocols: Chronic Low Back Pain
  • Nutraceutical Protocols: Myofascial Pain Syndrome
  • Acupuncture for Sciatica
  • Acupuncture: Trigger Points and Acupuncture Points

Low Back Pain (LBP) – Overview

• LBP – Arachnoiditis
• LBP – Superior Cluneal Nerve Entrapment
• LBP – Disc Pain
• LBP – Facet Pain
• LBP – Failed Back Surgery Syndrome
• LBP – Myofascial Pain
• LBP – Sacroiliac (SI) Joint Pain
• LBP – Sciatica
• LBP – Spinal Stenosis

Treatment:

• Epidural Injections
• Facet Joint Injections and Nerve Procedures
• Heat & Cold Therapy
• Inversion Therapy
• Massage Therapy
• Physical Therapy
• Trigger Point Therapy
• Nutraceutical Protocols: Chronic Low Back Pain
• Nutraceutical Protocols: Myofascial Pain Syndrome

Key to Links:

• Grey text – handout
• Red text – another page on this website
• Blue text – Journal publication

Definitions and Terms Related to Pain

Nutraceutical Protocols:

Chronic Low Back Pain

The complaints of pain in the lower back are often lumped under one umbrella term, “chronic low back pain,” but the fact is that low back pain may stem from a number of underlying pathologic conditions. These conditions can be a sole source of pain, or usually, there are multiple sources of pain. Identifying. the source(s) of pain is important when determining the best approach for managing that pain with nutraceuticals.

   The following sources of chronic low back pain reviewed here include:

1. Degenerative Disc Disease (bulging discs)
2. Herniated Discs
3. Facetogenic Pain (arthritis of the facet joints)
4. Nerve Root Compression (“pinched nerve”)
5. Central Spinal Stenosis (CSS)
6. Myofascial Pain

The evidence base for nutraceutical interventions in these conditions varies, with stronger mechanistic and preclinical data for degenerative disc disease, limited direct evidence for spinal stenosis, and emerging evidence for myofascial pain.[1][2][3][4][5][6][7][8][9][10]

1. DEGENERATIVE DISC DISEASE (DDD)

   Pathophysiology Targets for Treatment:

1. Extracellular matrix degradation
2. Nucleus pulposus cell aging and death
3. Oxidative stress
4. Chronic low-grade inflammation
5. Loss of disc hydration

   Evidence Summary:

Intervertebral disc degeneration (IDD) involves complex pathophysiology including inflammation, oxidative stress, ECM degradation, and cellular apoptosis.[12][13] Natural products including flavonoids (quercetin), phenolic compounds (curcumin, resveratrol), and terpenoids exert therapeutic effects by modulating SIRT1, NF-κB, MAPK, PI3K/Akt, and Nrf2 pathways.[12] Omega-3 fatty acid supplementation reduces systemic inflammation and has protective effects on disc degeneration progression.[6] Melatonin demonstrates anti-inflammatory, antioxidant, and anti-apoptotic properties relevant to IDD treatment.[6]

   Preclinical Evidence:

Polyphenols including resveratrol, curcumin, and quercetin inhibit ROS production, scavenge free radicals, and reduce hydrogen peroxide production in nucleus pulposus cells.[13] These compounds target multiple pathways involved in disc degeneration including matrix metalloproteinase inhibition and promotion of ECM synthesis.

   Nutraceuticals Recommended:

The nutraceuticals recommended for managing of DDD are chosen to target the underlying mechanisms of the disease process. The benefits of these compounds may take 3 to 6 months for full impact to be identified.

   Protocol Notes:

• Focus on antioxidant and anti-inflammatory polyphenols targeting disc cell pathways[12][13]
• Omega-3 supplementation has preclinical evidence for reducing disc degeneration[6]
• Melatonin addresses multiple DDD mechanisms including inflammation, oxidative stress, and apoptosis[6]
• Most evidence is preclinical; clinical trials specifically for DDD and nutraceuticals are limited
• Combine with weight management and physical therapy for optimal outcomes

2. HERNIATED NUCLEUS PULPOSUS (HNP)

A herniated nucleus pulposus (HNP) occurs when the soft, jelly-like center of an intervertebral disc pushes through a break  in the outer ring (annulus fibrosus). An HNP can result in pain if it compresses spinal nerves and, if the compression is severe, it can also lead to numbness or weakness correlating with the individual nerve that is affected. Besides causing pain with compression, the contents of the HNP can be irritating to the surrounding tissues, causing inflammation and pain.. Symptoms may include radiating pain (sciatica), numbness, tingling, or weakness in the legs.

Causes of HNP include age-related degeneration, improper lifting, or acute trauma. While most cases improve in a few weeks with conservative treatment (rest, PT), severe or persistent inflammation, or compression of surrounding tissues, may result in chronic pain and in some cases, may benefit from injections or surgery.

   Pathophysiology Targeted:

• Disc-mediated inflammation
• Nerve root compression
• Neuroinflammation
• Oxidative stress

These conditions cause degeneration and degradation of the nerve body and and its myelin sheath, the protective tissue that wraps around nerve fibers (axons) like insulation on an electrical wire. As an insulator, the myelin sheath increases the speed and efficiency of nerve signal transmission which can be degraded under these conditions.

   Treatments:

1. Conventional, Non-surgical: Physical therapy, anti-inflammatory medications (NSAIDs), exercise, epidural steroid injections, and lifestyle changes.
2. Surgical: Generally considered if conservative treatment fails for 6–12 months, including spinal fusion or artificial disc replacement.
3. Nutraceuticals to address underlying pathology and pain processing.

 Evidence Summary:

A prospective study demonstrated that nutraceutical supplements (ALA + PEA + myrrh) combined with pharmacological therapy significantly improved ODI, NRS, and physical function scores compared to pharmacological therapy alone, with reduced opioid requirements (40% vs 60% requiring adjuvant opioids).[1] Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress, and nociceptive factors while potentially promoting disc height recovery.[2]

   Clinical Trial Evidence:

In patients with acute radicular LBP due to disc herniation, the combination of pharmacological therapy + nutraceuticals (ALA, PEA, myrrh) showed:[1]

1. 1. – Significant improvement in pain  vs pharmacotherapy alone
   2. – Reduced percentage of patience requiring opioid therapy: 40% vs 60%
   3. – Improved physical component summary scores

   Protocol Notes:

• ALA + PEA combination has direct clinical evidence for radiculopathy[1]
• Curcumin may have disease-modifying effects on disc degeneration[2]
• Consider higher melatonin doses (5–10 mg) for neuropathic component
• Polyphenols (resveratrol, quercetin, curcumin) target IDD pathways via SIRT1, NF-κB, Nrf2[12][13]
• Multimodal approach combining nutraceuticals with physical therapy recommended

—

3. FACETOGENIC PAIN

The facet joints—the small, stabilizing joints between vertebrae.Facetogenic pain is a common, chronic source of back or neck pain caused by arthritis,  injury, inflammation, or degeneration of the facet joints—the small, stabilizing joints between vertebrae. Symptoms include localized stiffness, reduced mobility, and pain radiating to the buttocks or thighs, often worsening with extension, twisting, or prolonged standing.

   Pathophysiology Targeted:

• Facet joint inflammation
• Cartilage degeneration, Synovial Inflammation
• Mechanical stress

    Treatments:

1. Conventional, Non-surgical: Physical therapy, anti-inflammatory medications (NSAIDs), exercise, interventional procedures like medial branch blocks and radiofrequency ablation.and lifestyle changes.
2. Nutraceuticals to address underlying pathology and pain processing.

 Evidence Summary:

Facetogenic pain is primarily inflammatory/nociceptive in nature. Evidence supports anti-inflammatory nutraceuticals including curcumin, Boswellia, and omega-3 fatty acids for joint pain.[14][7][8] A meta-analysis showed Boswellia serrata extract and curcumin had large effect sizes for pain reduction in osteoarthritis.[8]

Devil’s Claw + Turmeric + Bromelain Combination: A clinical study showed this combination (AINAT 650 mg) provided clinically relevant pain improvement in both acute and chronic OA pain, with excellent tolerance and no withdrawals due to side effects.[15]

   Protocol Notes:

• Emphasize anti-inflammatory agents (curcumin, Boswellia, omega-3)
• Facetogenic pain responds to similar interventions as OA
• Consider collagen hydrolysate for potential cartilage support
• Conditional evidence-based recommendations exist for curcumin, omega-3, melatonin, vitamin D[14]
• May reduce NSAID requirements with consistent supplementation

—

4. NERVE ROOT COMPRESSION/IRRITATION

• Symptoms: Common symptoms include sharp or burning pain that radiates down limbs (sciatica), numbness, tingling, and muscle weakness.
• Causes: Often caused by degenerative conditions such as herniated discs, spinal stenosis (narrowing of the spine), arthritis, or bone spurs.
• Location: lower back pain radiating to the buttock, hip, and leg, often with weakness in the quadriceps, resulting in weakness, such as lifting your leg up while sitting in a chair.

   Pathophysiology Targeted:

1. Mechanical Compression
2. neuroinflammation
3. Oxidative Stress,

–> Leading to demyelination, spinal cord (dorsal root ganglion) pain sensitization

   Treatments:

1. Conventional, Non-surgical: Physical therapy, anti-inflammatory medications (NSAIDs), exercise, epidural steroid injections, and lifestyle changes.
2. Surgical: Generally considered if conservative treatment fails for 6–12 months, including spinal fusion or artificial disc replacement.
3. Nutraceuticals to address underlying pathology and pain processing.

   Evidence Summary:

This condition shares mechanisms with both HNP-related radiculopathy and neuropathic pain. Nutraceuticals targeting oxidative stress and neuroinflammation show benefit. A combination supplement (ALC, ALA, quercetin, bromelain, B vitamins) enhanced recovery of sensory fiber function after lumbar disc decompression.[16] Antioxidants attenuate established pain, oxidative stress, and neuroinflammation in radiculopathy models.[17]

Magnesium for LBP with Neuropathic Component: A double-blind RCT showed sequential IV then oral magnesium therapy significantly reduced pain intensity, improved quality of life, and decreased analgesic consumption in chronic LBP patients with a neuropathic component.[5]

   Protocol Notes:

• Combine antioxidant (ALA, NAC) and anti-inflammatory (PEA, curcumin) approaches
• ALC + ALA + quercetin combination has clinical evidence for nerve root recovery[16]
• Higher melatonin doses (5–10 mg) for neuropathic component
• B-vitamin complex may synergize with gabapentinoids[18]
• Consider IV magnesium loading for severe cases[5]

—

5. CENTRAL SPINAL STENOSIS (CSS)

• Definition: Narrowing of the central canal where the spinal cord travels, causing compression of the spinal cord.
• Common Causes: Age-related degeneration, bone spurs (osteophytes), bulging or herniated discs, and thickened ligaments.
• Symptoms: Pain, numbness, tingling, or weakness in limbs, and in severe cases, loss of bladder/bowel control.
• Diagnosis: Confirmed via MRI or CT scan, usually after a clinical examination of symptoms.
• Treatment Options:
  1. Conservative: Physical therapy, anti-inflammatory medications, and exercise to relieve pressure.
  2. Surgical: Decompression surgery (e.g., laminectomy) to widen the canal in severe cases.
  3. Nutraceuticals to address underlying pathology and pain processing.

   Pathophysiology Targeted:

Neurogenic claudication, nerve root ischemia, ligamentum flavum hypertrophy, chronic inflammation, central sensitization

   Evidence Summary:

Lumbar spinal stenosis (LSS) causing neurogenic claudication has limited high-quality evidence for pharmacological interventions.[19][9] Guidelines recommend multimodal nonpharmacological care including exercise, manual therapy, and education.[19] The North American Spine Society states insufficient evidence exists for most pharmacological treatments.[9]

A nutraceutical approach may target underlying inflammation and neurogenic components, though direct clinical trial evidence is lacking.

   Guideline Recommendations:

Clinical practice guidelines recommend against NSAIDs, calcitonin, methylcobalamin, paracetamol, opioids, muscle relaxants, and gabapentin for LSS with neurogenic claudication.[19] Multimodal care with manual therapy and exercise shows moderate-quality evidence for benefit.[10]

   Protocol Notes:

• Evidence for nutraceuticals specifically in spinal stenosis is limited; recommendations extrapolated from related conditions
• Multimodal nonpharmacological care (exercise, manual therapy) has strongest evidence[19][10]
• Focus on anti-inflammatory and neuroprotective agents
• Physical therapy and walking programs remain cornerstone of management[9]
• Consider as adjunct to structured exercise program rather than primary intervention

—

6. MYOFASCIAL PAIN SYNDROME (MPS)

• Trigger points: Tender knots in the muscles that produce localized or referred pain.
• Restricted Range of Motion: Stiffness and reduced mobility.
• Referred Pain: Pain that radiates to other areas of the body.
• Muscular Fatigue: General, chronic fatigue.

   Pathophysiology Targeted:

• Trigger point formation
• Muscle fiber dysfunction
• Local ischemia
• Peripheral and Central Sensitization
• Fascia inflammation

   Evidence Summary:

Myofascial pain syndrome (MPS) is characterized by trigger points within taut bands of muscle fibers causing localized and referred pain.[21][22] Evidence supports local anesthetic injections, dry needling, and manual therapy.[21] Pharmacological evidence is limited, with insufficient evidence for NSAIDs and inconclusive evidence for muscle relaxants.[21] Magnesium supplementation may reduce muscle soreness and improve recovery.[23][6] A multimodal treatment approach is recommended.[6]

   Magnesium Evidence:

Magnesium produces antinociceptive effects through NMDA receptor blockade and modulation of calcium and potassium channels.[6] Supplementation has been shown to reduce muscle soreness and improve perceived recovery in physically active individuals.[23]

   Protocol Notes:

• Acupuncture, Trigger point injections and dry needling have strongest evidence for MPS[21][22]
• Magnesium may help with muscle soreness and recovery[23][6]
• Manual therapy and myofascial release are effective nonpharmacological options[6]
• Address contributing factors: posture, ergonomics, stress, sleep
• Nutraceutical approach is adjunctive to physical interventions
• Consider overlap with fibromyalgia if widespread pain present

—

COMPARATIVE SUMMARY TABLE

Key points regarding the evidence base:

• Degenerative Disc Disease: The strongest mechanistic evidence comes from preclinical studies showing polyphenols (curcumin, resveratrol, quercetin) target multiple pathways including SIRT1, NF-κB, and Nrf2 involved in disc degeneration.[1][3] Omega-3 supplementation has demonstrated protective effects on disc degeneration progression in animal models.[2] Melatonin shows promise for its anti-inflammatory, antioxidant, and anti-apoptotic properties.[4]
• Central Spinal Stenosis: Direct evidence for nutraceuticals is limited. Clinical practice guidelines recommend multimodal nonpharmacological care (exercise, manual therapy) as first-line treatment.[5][6] The nutraceutical recommendations are extrapolated from related conditions targeting neurogenic pain and inflammation.
• Myofascial Pain: Evidence supports trigger point injections and manual therapy as primary interventions.[7][8] Magnesium supplementation has evidence for reducing muscle soreness and improving recovery, making it a reasonable adjunctive agent.[9][10]

REFERENCES

1. Latini E, Bonasia G, Petroselli L, et al. Alpha-Lipoic Acid, Palmitoylethanolamide, Myrrh, and Oxygen-Ozone Therapy Improve Pharmacological Therapy in Acute Painful Lumbosacral Radiculopathy Due to Herniated Disc. Pain Physician. 2023;26(4):E363-E373.

2. Xiao L, Ding M, Fernandez A, et al. Curcumin Alleviates Lumbar Radiculopathy by Reducing Neuroinflammation, Oxidative Stress and Nociceptive Factors. European Cells Materials. 2017;33:279-293. doi:10.22203/eCM.v033a21.

3. Viña I, López-Moreno M. Meta-Analysis of Palmitoylethanolamide in Pain Management: Addressing Literature Gaps and Enhancing Understanding. Nutrition Reviews. 2025;83(7):e1604-e1618. doi:10.1093/nutrit/nuae203.

4. Di Cesare Mannelli L, D’Agostino G, Pacini A, et al. Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-alpha-mediated Mechanism. Mediators of Inflammation. 2013;2013:328797. doi:10.1155/2013/328797.

5. Mostacci B, Liguori R, Cicero AF. Nutraceutical Approach to Peripheral Neuropathies: Evidence From Clinical Trials. Current Drug Metabolism. 2018;19(5):460-468. doi:10.2174/1389200218666171031145419.

6. Wu Z, Chen J, Luo W, Kuang T. Natural Products for Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Potentials. Frontiers in Pharmacology. 2025;16:1605764. doi:10.3389/fphar.2025.1605764.

7. Park R, Ho AM, Pickering G, et al. Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.

8. Yin J, Wan L, Zhang K, et al. Progress of Melatonin in the Treatment of Intervertebral Disc Degeneration. Frontiers in Physiology. 2025;16:1529315. doi:10.3389/fphys.2025.1529315.

9. NaPier Z, Kanim LEA, Arabi Y, et al. Omega-3 Fatty Acid Supplementation Reduces Intervertebral Disc Degeneration. Medical Science Monitor. 2019;25:9531-9537. doi:10.12659/MSM.918649.

10. Goldberg RJ, Katz J. A Meta-Analysis of the Analgesic Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation for Inflammatory Joint Pain. Pain. 2007;129(1-2):210-23. doi:10.1016/j.pain.2007.01.020.

11. Kang L, Zhang H, [Jia](/rare-disease/juvenile-idiopathic-arthritis) C, Zhang R, Shen C. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals. Frontiers in Pharmacology. 2022;13:956355. doi:10.3389/fphar.2022.956355.

12. Boyd C, Crawford C, Berry K, Deuster P. Conditional Recommendations for Specific Dietary Ingredients as an Approach to Chronic Musculoskeletal Pain: Evidence-Based Decision Aid for Health Care Providers, Participants, and Policy Makers. Pain Medicine. 2019;20(7):1430-1448. doi:10.1093/pm/pnz051.

13. Liu X, Eyles J, McLachlan AJ, Mobasheri A. Which Supplements Can I Recommend to My Osteoarthritis Patients?. Rheumatology (Oxford). 2018;57(suppl_4):iv75-iv87. doi:10.1093/rheumatology/key005.*

14. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary Supplements for Treating Osteoarthritis: A Systematic Review and Meta-Analysis. British Journal of Sports Medicine. 2018;52(3):167-175. doi:10.1136/bjsports-2016-097333.

15. Conrozier T, Mathieu P, Bonjean M, et al. A Complex of Three Natural Anti-Inflammatory Agents Provides Relief of Osteoarthritis Pain. Alternative Therapies in Health and Medicine. 2014;20 Suppl 1:32-7.

16. Gazzeri R, Leoni MLG, Occhigrossi F. Efficacy of Percutaneous Laser Disc Decompression (PLDD) Combined With an Oral Food Supplement for Lumbar Disc Herniation. Journal of Clinical Medicine. 2024;13(17):5049. doi:10.3390/jcm13175049.

17. Kartha S, Weisshaar CL, Pietrofesa RA, Christofidou-Solomidou M, Winkelstein BA. Synthetic Secoisolariciresinol Diglucoside Attenuates Established Pain, Oxidative Stress and Neuroinflammation in a Rodent Model of Painful Radiculopathy. Antioxidants (Basel). 2020;9(12):E1209. doi:10.3390/antiox9121209.

18. Marchesi N, Govoni S, Allegri M. Non-Drug Pain Relievers Active on Non-Opioid Pain Mechanisms. Pain Practice. 2022;22(2):255-275. doi:10.1111/papr.13073.

19. Bussières A, Cancelliere C, Ammendolia C, et al. Non-Surgical Interventions for Lumbar Spinal Stenosis Leading to Neurogenic Claudication: A Clinical Practice Guideline. The Journal of Pain. 2021;22(9):1015-1039. doi:10.1016/j.jpain.2021.03.147.

20. Katz JN, Zimmerman ZE, Mass H, Makhni MC. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022;327(17):1688-1699. doi:10.1001/jama.2022.5921.

21. Ammendolia C, Hofkirchner C, Plener J, et al. Non-Operative Treatment for Lumbar Spinal Stenosis With Neurogenic Claudication: An Updated Systematic Review. BMJ Open. 2022;12(1):e057724. doi:10.1136/bmjopen-2021-057724.

22. Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. Effect of Vitamin D Supplementation on Pain: A Systematic Review and Meta-Analysis. Pain Physician. 2016;19(7):415-27.

23. Steen JP, Jaiswal KS, Kumbhare D. Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment. Muscle Nerve. 2025;71(5):889-910. doi:10.1002/mus.28377.

24. Galasso A, Urits I, An D, et al. A Comprehensive Review of the Treatment and Management of Myofascial Pain Syndrome. Current Pain and Headache Reports. 2020;24(8):43. doi:10.1007/s11916-020-00877-5.

25. Tarsitano MG, Quinzi F, Folino K, et al. Effects of Magnesium Supplementation on Muscle Soreness in Different Type of Physical Activities: A Systematic Review. Journal of Translational Medicine. 2024;22(1):629. doi:10.1186/s12967-024-05434-x.

26. Srebro D, Vuckovic S, Milovanovic A, et al. Magnesium in Pain Research: State of the Art. Current Medicinal Chemistry. 2017;24(4):424-434. doi:10.2174/0929867323666161213101744.

27. Flynn DM. Chronic Musculoskeletal Pain: Nonpharmacologic, Noninvasive Treatments. American Family Physician. 2020;102(8):465-477.

28. Xie Y, Farrell SF, Armfield N, Sterling M. Serum Vitamin D and Chronic Musculoskeletal Pain: A Cross-Sectional Study of 349,221 Adults in the UK. The Journal of Pain. 2024;25(9):104557. doi:10.1016/j.jpain.2024.104557.

29. Hargreaves IP, Mantle D. Targeted Treatment of Age-Related Fibromyalgia With Supplemental Coenzyme Q10. Advances in Experimental Medicine and Biology. 2021;1286:77-85. doi:10.1007/978-3-030-55035-6_5.*

References

1. Natural Products for Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Potentials. Wu Z, Chen J, Luo W, Kuang T. Frontiers in Pharmacology. 2025;16:1605764. doi:10.3389/fphar.2025.1605764.
2. Omega-3 Fatty Acid Supplementation Reduces Intervertebral Disc Degeneration. NaPier Z, Kanim LEA, Arabi Y, et al. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2019;25:9531-9537. doi:10.12659/MSM.918649.
3. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals. Kang L, Zhang H, Jia C, Zhang R, Shen C. Frontiers in Pharmacology. 2022;13:956355. doi:10.3389/fphar.2022.956355.
4. Progress of Melatonin in the Treatment of Intervertebral Disc Degeneration. Yin J, Wan L, Zhang K, et al. Frontiers in Physiology. 2025;16:1529315. doi:10.3389/fphys.2025.1529315.
5. Non-Surgical Interventions for Lumbar Spinal Stenosis Leading to Neurogenic Claudication: A Clinical Practice Guideline. Bussières A, Cancelliere C, Ammendolia C, et al. The Journal of Pain. 2021;22(9):1015-1039. doi:10.1016/j.jpain.2021.03.147.
6. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. Katz JN, Zimmerman ZE, Mass H, Makhni MC. JAMA. 2022;327(17):1688-1699. doi:10.1001/jama.2022.5921.
7. Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment. Steen JP, Jaiswal KS, Kumbhare D. Muscle & Nerve. 2025;71(5):889-910. doi:10.1002/mus.28377.
8. A Comprehensive Review of the Treatment and Management of Myofascial Pain Syndrome. Galasso A, Urits I, An D, et al. Current Pain and Headache Reports. 2020;24(8):43. doi:10.1007/s11916-020-00877-5.
9. Effects of Magnesium Supplementation on Muscle Soreness in Different Type of Physical Activities: A Systematic Review. Tarsitano MG, Quinzi F, Folino K, et al. Journal of Translational Medicine. 2024;22(1):629. doi:10.1186/s12967-024-05434-x.
10. Magnesium in Pain Research: State of the Art. Srebro D, Vuckovic S, Milovanovic A, et al. Current Medicinal Chemistry. 2017;24(4):424-434. doi:10.2174/0929867323666161213101744.
11. Natural Products Can Modulate Inflammation in Intervertebral Disc Degeneration. Liu Z, Zhu J, Liu H, Fu C. Frontiers in Pharmacology. 2023;14:1150835. doi:10.3389/fphar.2023.1150835.
12. Polyphenols as Potential Antioxidants for the Treatment of Intervertebral Disc Degeneration. Li XL, Yu XY, Tao YA, et al. Current Medicinal Chemistry. 2025;32(17):3405-3422. doi:10.2174/0109298673287391231228081400.
13. Lumbar Spinal Stenosis: Diagnosis and Management. Webb CW, Aguirre K, Seidenberg PH. American Family Physician. 2024;109(4):350-359.
14. Clinical Effectiveness of Conservative Treatments on Lumbar Spinal Stenosis: A Network Meta-Analysis. Chen X, Zheng Z, Lin J. Frontiers in Pharmacology. 2022;13:859296. doi:10.3389/fphar.2022.859296.
15. Myofascial Pain – A Major Player in Musculoskeletal Pain. Lam C, Francio VT, Gustafson K, et al. Best Practice & Research. Clinical Rheumatology. 2024;38(1):101944. doi:10.1016/j.berh.2024.101944.
16. Fibromyalgia: Diagnosis and Management. Winslow BT, Vandal C, Dang L. American Family Physician. 2023;107(2):137-144.
17. Treatment and Management of Myofascial Pain Syndrome. Urits I, Charipova K, Gress K, et al. Best Practice & Research. Clinical Anaesthesiology. 2020;34(3):427-448. doi:10.1016/j.bpa.2020.08.003.
18. Chronic Musculoskeletal Pain: Nonpharmacologic, Noninvasive Treatments. Flynn DM. American Family Physician. 2020;102(8):465-477.
19. FDA Orange Book. FDA Orange Book.
20. Effects of Magnesium Supplementation on Muscle Soreness and Performance. Reno AM, Green M, Killen LG, et al. Journal of Strength and Conditioning Research. 2022;36(8):2198-2203. doi:10.1519/JSC.0000000000003827.
21. Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Park R, Ho AM, Pickering G, et al. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.
22. Serum Magnesium Levels and Their Association With Sleep Quality and Disease Severity in Fibromyalgia Syndrome: An Observational Cross-Sectional Study. Alisik T, Reis Altan YC, Olkay SG, Sahingoz Bakirci E. Medicine. 2025;104(29):e43446. doi:10.1097/MD.0000000000043446.
23. Magnesium for Skeletal Muscle Cramps. Garrison SR, Korownyk CS, Kolber MR, et al. The Cochrane Database of Systematic Reviews. 2020;9:CD009402. doi:10.1002/14651858.CD009402.pub3.
24. Nutraceutical Interactions with Opioid Pain Processing

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

.